請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/57261
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 程蘊菁(Yen-Ching Chen) | |
dc.contributor.author | Chih-Hao Chen | en |
dc.contributor.author | 陳志昊 | zh_TW |
dc.date.accessioned | 2021-06-16T06:39:35Z | - |
dc.date.available | 2020-08-26 | |
dc.date.copyright | 2020-08-26 | |
dc.date.issued | 2020 | |
dc.date.submitted | 2020-07-22 | |
dc.identifier.citation | Agrawal, V., Marinescu, V., Agarwal, M., McCullough, P. A. (2009). Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol, 6(4), 301-311. doi:10.1038/nrcardio.2009.11 Akchurin, O. M., Kaskel, F. (2015). Update on inflammation in chronic kidney disease. Blood Purif, 39(1-3), 84-92. doi:10.1159/000368940 Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., . . . Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 270-279. doi:10.1016/j.jalz.2011.03.008 Alzheimer Disease International: Numbers of people with dementia. Retrieved from https://www.alz.co.uk/research/statistics Araujo, N. B., Barca, M. L., Engedal, K., Coutinho, E. S., Deslandes, A. C., Laks, J. (2011). Verbal fluency in Alzheimer's disease, Parkinson's disease, and major depression. Clinics (Sao Paulo), 66(4), 623-627. doi:10.1590/s1807-59322011000400017 Arbuthnott, K., Frank, J. (2000). Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol, 22(4), 518-528. doi:10.1076/1380-3395(200008)22:4;1-0;FT518 Arvanitakis, Z., Lucas, J. A., Younkin, L. H., Younkin, S. G., Graff-Radford, N. R. (2002). Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer Dis Assoc Disord, 16(3), 187-190. Auriel, E., Kliper, E., Shenhar-Tsarfaty, S., Molad, J., Berliner, S., Shapira, I., . . . Ben Assayag, E. (2016). Impaired renal function is associated with brain atrophy and poststroke cognitive decline. Neurology, 86(21), 1996-2005. doi:10.1212/WNL.0000000000002699 Baliki, M. N., Schnitzer, T. J., Bauer, W. R., Apkarian, A. V. (2011). Brain morphological signatures for chronic pain. PLoS One, 6(10), e26010. doi:10.1371/journal.pone.0026010 Barnes, J., Ridgway, G. R., Bartlett, J., Henley, S. M., Lehmann, M., Hobbs, N., . . . Fox, N. C. (2010). Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage, 53(4), 1244-1255. doi:10.1016/j.neuroimage.2010.06.025 Barzilay, J. I., Morgan, T. M., Murray, A. M., Bryan, R. N., Williamson, J. D., Schnall, A., Launer, L. J. (2016). Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study. J Gerontol A Biol Sci Med Sci, 71(6), 803-810. doi:10.1093/gerona/glv187 Baumgart, M., Snyder, H. M., Carrillo, M. C., Fazio, S., Kim, H., Johns, H. (2015). Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective. Alzheimers Dement, 11(6), 718-726. doi:10.1016/j.jalz.2015.05.016 Ben Assayag, E., Eldor, R., Korczyn, A. D., Kliper, E., Shenhar-Tsarfaty, S., Tene, O., . . . Auriel, E. (2017). Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline. Stroke, 48(9), 2368-2374. doi:10.1161/STROKEAHA.117.017709 Berger, I., Wu, S., Masson, P., Kelly, P. J., Duthie, F. A., Whiteley, W., . . . Webster, A. C. (2016). Cognition in chronic kidney disease: a systematic review and meta-analysis. BMC Med, 14(1), 206. doi:10.1186/s12916-016-0745-9 Buchman, A. S., Tanne, D., Boyle, P. A., Shah, R. C., Leurgans, S. E., Bennett, D. A. (2009). Kidney function is associated with the rate of cognitive decline in the elderly. Neurology, 73(12), 920-927. doi:10.1212/WNL.0b013e3181b72629 Bugnicourt, J. M., Godefroy, O., Chillon, J. M., Choukroun, G., Massy, Z. A. (2013). Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol, 24(3), 353-363. doi:10.1681/ASN.2012050536 Burggren, A. C., Zeineh, M. M., Ekstrom, A. D., Braskie, M. N., Thompson, P. M., Small, G. W., Bookheimer, S. Y. (2008). Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage, 41(4), 1177-1183. doi:10.1016/j.neuroimage.2008.03.039 Busovaca, E., Zimmerman, M. E., Meier, I. B., Griffith, E. Y., Grieve, S. M., Korgaonkar, M. S., . . . Brickman, A. M. (2016). Is the Alzheimer's disease cortical thickness signature a biological marker for memory? Brain Imaging Behav, 10(2), 517-523. doi:10.1007/s11682-015-9413-5 Chapman, J., Estupinan, J., Asherov, A., Goldfarb, L. G. (1996). A simple and efficient method for apolipoprotein E genotype determination. Neurology, 46(5), 1484-1485. doi:10.1212/wnl.46.5.1484-a Chapter 1: Definition and classification of CKD. (2013). Kidney Int Suppl (2011), 3(1), 19-62. doi:10.1038/kisup.2012.64 Chapter 2: Definition, identification, and prediction of CKD progression. (2013). Kidney Int Suppl (2011), 3(1), 63-72. doi:10.1038/kisup.2012.65 Chen, C. H., Chen, Y. F., Chiu, M. J., Chen, T. F., Tsai, P. H., Chen, J. H., . . . Chen, Y. C. (2017). Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population. Sci Rep, 7(1), 2337. doi:10.1038/s41598-017-02537-y Chen, J., Lin, I. T., Zhang, H., Lin, J., Zheng, S., Fan, M., Zhang, J. (2015). Reduced cortical thickness, surface area in patients with chronic obstructive pulmonary disease: a surface-based morphometry and neuropsychological study. Brain Imaging Behav. doi:10.1007/s11682-015-9403-7 Chen, J. H., Lin, K. P., Chen, Y. C. (2009). Risk factors for dementia. J Formos Med Assoc, 108(10), 754-764. doi:10.1016/s0929-6646(09)60402-2 Cho, E. B., Seo, S. W., Kim, H., Lee, J. M., Yoon, U., Im, K., . . . Na, D. L. (2013). Effect of kidney dysfunction on cortical thinning in patients with probable Alzheimer's disease dementia. J Alzheimers Dis, 33(4), 961-968. doi:10.3233/JAD-2012-121180 Chronic Kidney Disease Prognosis, C., Matsushita, K., van der Velde, M., Astor, B. C., Woodward, M., Levey, A. S., . . . Gansevoort, R. T. (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet, 375(9731), 2073-2081. doi:10.1016/S0140-6736(10)60674-5 Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., . . . Levey, A. S. (2007). Prevalence of chronic kidney disease in the United States. Jama, 298(17), 2038-2047. doi:10.1001/jama.298.17.2038 Couser, W. G., Remuzzi, G., Mendis, S., Tonelli, M. (2011). The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int, 80(12), 1258-1270. doi:10.1038/ki.2011.368 Coutinho, A. M., Coutu, J. P., Lindemer, E. R., Rosas, H. D., Rosen, B. R., Salat, D. H. (2016). Differential associations between systemic markers of disease and cortical thickness in healthy middle-aged and older adults. Neuroimage, 146, 19-27. doi:10.1016/j.neuroimage.2016.11.021 Coutinho, A. M., Coutu, J. P., Lindemer, E. R., Rosas, H. D., Rosen, B. R., Salat, D. H. (2017). Differential associations between systemic markers of disease and cortical thickness in healthy middle-aged and older adults. Neuroimage, 146, 19-27. doi:10.1016/j.neuroimage.2016.11.021 de Bresser, J., Reijmer, Y. D., van den Berg, E., Breedijk, M. A., Kappelle, L. J., Viergever, M. A., . . . Utrecht Diabetic Encephalopathy Study, G. (2010). Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord, 30(5), 381-386. doi:10.1159/000321354 de la Torre, J. (2018). The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging. J Alzheimers Dis, 63(1), 35-52. doi:10.3233/JAD-180004 Deckers, K., Camerino, I., van Boxtel, M. P., Verhey, F. R., Irving, K., Brayne, C., . . . Kohler, S. (2017). Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies. Neurology, 88(2), 198-208. doi:10.1212/WNL.0000000000003482 Desikan, R. S., Segonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., . . . Killiany, R. J. (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage, 31(3), 968-980. doi:10.1016/j.neuroimage.2006.01.021 Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., . . . Buckner, R. L. (2009). The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex, 19(3), 497-510. doi:10.1093/cercor/bhn113 Dickerson, B. C., Feczko, E., Augustinack, J. C., Pacheco, J., Morris, J. C., Fischl, B., Buckner, R. L. (2009). Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area. Neurobiol Aging, 30(3), 432-440. doi:10.1016/j.neurobiolaging.2007.07.022 Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., . . . Washington Dc, U. S. A. (2016). Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. Alzheimers Dement, 12(3), 292-323. doi:10.1016/j.jalz.2016.02.002 Elias, M. F., Dore, G. A., Davey, A. (2013). Kidney disease and cognitive function. Contrib Nephrol, 179, 42-57. doi:10.1159/000346722 Etgen, T. (2015). Kidney disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther, 7(1), 29. doi:10.1186/s13195-015-0115-4 Etgen, T., Chonchol, M., Forstl, H., Sander, D. (2012). Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol, 35(5), 474-482. doi:10.1159/000338135 Farias, S. T., Mungas, D., Reed, B. R., Harvey, D., DeCarli, C. (2009). Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol, 66(9), 1151-1157. doi:10.1001/archneurol.2009.106 Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A., Mayeux, R., . . . van Duijn, C. M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama, 278(16), 1349-1356. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9343467 Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I., Zimmerman, R. A. (1987). MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol, 149(2), 351-356. doi:10.2214/ajr.149.2.351 Fennema-Notestine, C., Panizzon, M. S., Thompson, W. R., Chen, C. H., Eyler, L. T., Fischl, B., . . . Kremen, W. S. (2011). Presence of ApoE epsilon4 allele associated with thinner frontal cortex in middle age. J Alzheimers Dis, 26 Suppl 3, 49-60. doi:10.3233/jad-2011-0002 Filler, G., Bokenkamp, A., Hofmann, W., Le Bricon, T., Martinez-Bru, C., Grubb, A. (2005). Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem, 38(1), 1-8. doi:10.1016/j.clinbiochem.2004.09.025 Fischl, B., Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A, 97(20), 11050-11055. doi:10.1073/pnas.200033797 Folstein, M. F., Folstein, S. E., McHugh, P. R. (1975). 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 12(3), 189-198. doi:10.1016/0022-3956(75)90026-6 Frisoni, G. B., Fox, N. C., Jack, C. R., Jr., Scheltens, P., Thompson, P. M. (2010). The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol, 6(2), 67-77. doi:10.1038/nrneurol.2009.215 Frisoni, G. B., Galluzzi, S., Pantoni, L., Filippi, M. (2007). The effect of white matter lesions on cognition in the elderly--small but detectable. Nat Clin Pract Neurol, 3(11), 620-627. doi:10.1038/ncpneuro0638 Ghiso, J., Shayo, M., Calero, M., Ng, D., Tomidokoro, Y., Gandy, S., . . . Frangione, B. (2004). Systemic catabolism of Alzheimer's Abeta40 and Abeta42. J Biol Chem, 279(44), 45897-45908. doi:10.1074/jbc.M407668200 Grossman, M., Irwin, D. J. (2016). The Mental Status Examination in Patients With Suspected Dementia. Continuum (Minneap Minn), 22(2 Dementia), 385-403. doi:10.1212/CON.0000000000000298 Gu, X., Hof, P. R., Friston, K. J., Fan, J. (2013). Anterior insular cortex and emotional awareness. J Comp Neurol, 521(15), 3371-3388. doi:10.1002/cne.23368 Hansson, O., Janelidze, S., Hall, S., Magdalinou, N., Lees, A. J., Andreasson, U., . . . Blennow, K. (2017). Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder. Neurology, 88(10), 930-937. doi:10.1212/wnl.0000000000003680 Hassan, A., Hunt, B. J., O'Sullivan, M., Bell, R., D'Souza, R., Jeffery, S., . . . Markus, H. S. (2004). Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain, 127(Pt 1), 212-219. doi:10.1093/brain/awh023 Hayata, T. T., Bergo, F. P., Rezende, T. J., Damasceno, A., Damasceno, B. P., Cendes, F., . . . Balthazar, M. L. (2015). Cortical correlates of affective syndrome in dementia due to Alzheimer's disease. Arq Neuropsiquiatr, 73(7), 553-560. doi:10.1590/0004-282x20150068 Hilal, S., Xin, X., Ang, S. L., Tan, C. S., Venketasubramanian, N., Niessen, W. J., . . . Ikram, M. K. (2015). Risk Factors and Consequences of Cortical Thickness in an Asian Population. Medicine (Baltimore), 94(23), e852. doi:10.1097/MD.0000000000000852 Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O'Callaghan, C. A., Lasserson, D. S., Hobbs, F. D. (2016). Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One, 11(7), e0158765. doi:10.1371/journal.pone.0158765 Hubbard, C. S., Becerra, L., Heinz, N., Ludwick, A., Rasooly, T., Wu, R., . . . Nurko, S. (2016). Abdominal Pain, the Adolescent and Altered Brain Structure and Function. PLoS One, 11(5), e0156545. doi:10.1371/journal.pone.0156545 Hwang, S. J., Tsai, J. C., Chen, H. C. (2010). Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton), 15 Suppl 2, 3-9. doi:10.1111/j.1440-1797.2010.01304.x Ikram, M. A., Vernooij, M. W., Hofman, A., Niessen, W. J., van der Lugt, A., Breteler, M. M. (2008). Kidney function is related to cerebral small vessel disease. Stroke, 39(1), 55-61. doi:10.1161/STROKEAHA.107.493494 International, A. s. D. (2015). World Alzheimer Report 2015 the Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. Jack, C. R., Jr., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., . . . Trojanowski, J. Q. (2013). Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol, 12(2), 207-216. doi:10.1016/S1474-4422(12)70291-0 Jack, C. R., Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., . . . Trojanowski, J. Q. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol, 9(1), 119-128. doi:10.1016/s1474-4422(09)70299-6 Jack, C. R., Jr., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., . . . Petersen, R. C. (2017). Defining imaging biomarker cut points for brain aging and Alzheimer's disease. Alzheimers Dement, 13(3), 205-216. doi:10.1016/j.jalz.2016.08.005 Jorgensen, K. N., Skjaervo, I., Morch-Johnsen, L., Haukvik, U. K., Lange, E. H., Melle, I., . . . Agartz, I. (2015). Cigarette smoking is associated with thinner cingulate and insular cortices in patients with severe mental illness. J Psychiatry Neurosci, 40(4), 241-249. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478057/pdf/jpn-40-241.pdf Jubault, T., Gagnon, J. F., Karama, S., Ptito, A., Lafontaine, A. L., Evans, A. C., Monchi, O. (2011). Patterns of cortical thickness and surface area in early Parkinson's disease. Neuroimage, 55(2), 462-467. doi:10.1016/j.neuroimage.2010.12.043 Kaur, S. S., Gonzales, M. M., Eagan, D. E., Goudarzi, K., Tanaka, H., Haley, A. P. (2014). Inflammation as a mediator of the relationship between cortical thickness and metabolic syndrome. Brain Imaging Behav. doi:10.1007/s11682-014-9330-z Khachaturian, Z. S., Kuller, L. H., Khachaturian, A. S. (2019). Strategic goals and roadmap for dementia prevention by stroke prevention. Alzheimers Dement, 15(7), 865-869. doi:10.1016/j.jalz.2019.06.003 Khatri, M., Wright, C. B., Nickolas, T. L., Yoshita, M., Paik, M. C., Kranwinkel, G., . . . DeCarli, C. (2007). Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke, 38(12), 3121-3126. doi:10.1161/strokeaha.107.493593 Knopman, D. S., Lundt, E. S., Therneau, T. M., Vemuri, P., Lowe, V. J., Kantarci, K., . . . Jack, C. R. (2019). Entorhinal cortex tau, amyloid-beta, cortical thickness and memory performance in non-demented subjects. Brain, 142(4), 1148-1160. doi:10.1093/brain/awz025 Knopman, D. S., Mosley, T. H., Jr., Bailey, K. R., Jack, C. R., Jr., Schwartz, G. L., Turner, S. T. (2008). Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships. J Neurol Sci, 271(1-2), 53-60. doi:10.1016/j.jns.2008.03.009 Kobayashi, M., Hirawa, N., Yatsu, K., Kobayashi, Y., Yamamoto, Y., Saka, S., . . . Umemura, S. (2009). Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant, 24(1), 201-207. doi:10.1093/ndt/gfn419 Kobayashi, S., Ikeda, T., Moriya, H., Ohtake, T., Kumagai, H. (2004). Asymptomatic cerebral lacunae in patients with chronic kidney disease. American Journal of Kidney Diseases, 44(1), 35-41. doi:10.1053/j.ajkd.2004.03.026 Kumai, Y., Kamouchi, M., Hata, J., Ago, T., Kitayama, J., Nakane, H., . . . Kitazono, T. (2012). Proteinuria and clinical outcomes after ischemic stroke. Neurology, 78(24), 1909-1915. doi:10.1212/WNL.0b013e318259e110 Kuriyama, N., Mizuno, T., Ohshima, Y., Yamada, K., Ozaki, E., Shigeta, M., . . . Watanabe, Y. (2013). Intracranial deep white matter lesions (DWLs) are associated with chronic kidney disease (CKD) and cognitive impairment: a 5-year follow-up magnetic resonance imaging (MRI) study. Arch Gerontol Geriatr, 56(1), 55-60. doi:10.1016/j.archger.2011.11.009 Langa, K. M. (2015). Is the risk of Alzheimer’s disease and dementia declining? Alzheimer's Research Therapy, 7(1). doi:10.1186/s13195-015-0118-1 Langa, K. M., Larson, E. B., Crimmins, E. M., Faul, J. D., Levine, D. A., Kabeto, M. U., Weir, D. R. (2016). A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. JAMA Intern Med. doi:10.1001/jamainternmed.2016.6807 Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., 3rd, Feldman, H. I., . . . Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Ann Intern Med, 150(9), 604-612. doi:10.7326/0003-4819-150-9-200905050-00006 Li, X., Yuan, J., Yang, L., Qin, W., Yang, S., Li, Y., . . . Hu, W. (2017). The significant effects of cerebral microbleeds on cognitive dysfunction: An updated meta-analysis. PLoS One, 12(9), e0185145. doi:10.1371/journal.pone.0185145 Liu, Y., Julkunen, V., Paajanen, T., Westman, E., Wahlund, L. O., Aitken, A., . . . AddNeuroMed, C. (2012). Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis. Neuroradiology, 54(9), 929-938. doi:10.1007/s00234-012-1005-0 Lourida, I., Soni, M., Thompson-Coon, J., Purandare, N., Lang, I. A., Ukoumunne, O. C., Llewellyn, D. J. (2013). Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology, 24(4), 479-489. doi:10.1097/EDE.0b013e3182944410 Lu, R., Kiernan, M. C., Murray, A., Rosner, M. H., Ronco, C. (2015). Kidney-brain crosstalk in the acute and chronic setting. Nat Rev Nephrol, 11(12), 707-719. doi:10.1038/nrneph.2015.131 Maleki, N., Barmettler, G., Moulton, E. A., Scrivani, S., Veggeberg, R., Spierings, E. L., . . . Borsook, D. (2015). Female migraineurs show lack of insular thinning with age. Pain, 156(7), 1232-1239. doi:10.1097/j.pain.0000000000000159 Manly, J. J., Tang, M. X., Schupf, N., Stern, Y., Vonsattel, J. P., Mayeux, R. (2008). Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol, 63(4), 494-506. doi:10.1002/ana.21326 Markwick, A., Zamboni, G., de Jager, C. A. (2012). Profiles of cognitive subtest impairment in the Montreal Cognitive Assessment (MoCA) in a research cohort with normal Mini-Mental State Examination (MMSE) scores. J Clin Exp Neuropsychol, 34(7), 750-757. doi:10.1080/13803395.2012.672966 McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr., Kawas, C. H., . . . Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 263-269. doi:10.1016/j.jalz.2011.03.005 Mehta, D., Pimentel, D. A., Nunez, M. Z., Abduljalil, A., Novak, V. (2014). Subclinical albuminuria is linked to gray matter atrophy in type 2 diabetes mellitus. Metabolism, 63(11), 1390-1397. doi:10.1016/j.metabol.2014.07.008 Miranda, A. S., Cordeiro, T. M., Dos Santos Lacerda Soares, T. M., Ferreira, R. N., Simoes, E. S. A. C. (2017). Kidney-brain axis inflammatory cross-talk: from bench to bedside. Clin Sci (Lond), 131(11), 1093-1105. doi:10.1042/CS20160927 Miwa, K., Tanaka, M., Okazaki, S., Furukado, S., Yagita, Y., Sakaguchi, M., . . . Kitagawa, K. (2014). Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology, 82(12), 1051-1057. doi:10.1212/WNL.0000000000000251 Mogi, M., Horiuchi, M. (2011). Clinical Interaction between Brain and Kidney in Small Vessel Disease. Cardiol Res Pract, 2011, 306189. doi:10.4061/2011/306189 Moodalbail, D. G., Reiser, K. A., Detre, J. A., Schultz, R. T., Herrington, J. D., Davatzikos, C., . . . Hooper, S. R. (2013). Systematic review of structural and functional neuroimaging findings in children and adults with CKD. Clin J Am Soc Nephrol, 8(8), 1429-1448. doi:10.2215/CJN.11601112 Murea, M., Hsu, F. C., Cox, A. J., Hugenschmidt, C. E., Xu, J., Adams, J. N., . . . Freedman, B. I. (2015). Structural and functional assessment of the brain in European Americans with mild-to-moderate kidney disease: Diabetes Heart Study-MIND. Nephrol Dial Transplant, 30(8), 1322-1329. doi:10.1093/ndt/gfv030 Ngandu, T., Lehtisalo, J., Solomon, A., Levalahti, E., Ahtiluoto, S., Antikainen, R., . . . Kivipelto, M. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet, 385(9984), 2255-2263. doi:10.1016/S0140-6736(15)60461-5 Organization, W. H. (2017). Fact sheet on dementia. http://www.who.int/en/news-room/fact-sheets/detail/dementia. Ossenkoppele, R., Smith, R., Ohlsson, T., Strandberg, O., Mattsson, N., Insel, P. S., . . . Hansson, O. (2019). Associations between tau, Abeta, and cortical thickness with cognition in Alzheimer disease. Neurology, 92(6), e601-e612. doi:10.1212/WNL.0000000000006875 Pantoni, L. (2010). Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol, 9(7), 689-701. doi:10.1016/S1474-4422(10)70104-6 Petersen, R. C. (2011). Clinical practice. Mild cognitive impairment. N Engl J Med, 364(23), 2227-2234. doi:10.1056/NEJMcp0910237 Pettigrew, C., Soldan, A., Zhu, Y., Wang, M. C., Brown, T., Miller, M., . . . Team, B. R. (2017). Cognitive reserve and cortical thickness in preclinical Alzheimer's disease. Brain Imaging Behav, 11(2), 357-367. doi:10.1007/s11682-016-9581-y Pettigrew, C., Soldan, A., Zhu, Y., Wang, M. C., Moghekar, A., Brown, T., . . . Team, B. R. (2016). Cortical thickness in relation to clinical symptom onset in preclinical AD. Neuroimage Clin, 12, 116-122. doi:10.1016/j.nicl.2016.06.010 Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., . . . Wallace, R. B. (2008). Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med, 148(6), 427-434. doi:10.7326/0003-4819-148-6-200803180-00005 Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., Ferri, C. P. (2013). The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement, 9(1), 63-75 e62. doi:10.1016/j.jalz.2012.11.007 Rosas, H. D., Liu, A. K., Hersch, S., Glessner, M., Ferrante, R. J., Salat, D. H., . . . Fischl, B. (2002). Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology, 58(5), 695-701. Rossi, A. F., Pessoa, L., Desimone, R., Ungerleider, L. G. (2009). The prefrontal cortex and the executive control of attention. Experimental brain research, 192(3), 489-497. doi:10.1007/s00221-008-1642-z Salat, D. H., Buckner, R. L., Snyder, A. Z., Greve, D. N., Desikan, R. S., Busa, E., . . . Fischl, B. (2004). Thinning of the cerebral cortex in aging. Cereb Cortex, 14(7), 721-730. doi:10.1093/cercor/bhh032 Schaeffner, E. S., van der Giet, M., Gaedeke, J., Tolle, M., Ebert, N., Kuhlmann, M. K., Martus, P. (2010). The Berlin initiative study: the methodology of exploring kidney function in the elderly by combining a longitudinal and cross-sectional approach. Eur J Epidemiol, 25(3), 203-210. doi:10.1007/s10654-010-9424-x Schmidt, E. L., Burge, W., Visscher, K. M., Ross, L. A. (2016). Cortical thickness in frontoparietal and cingulo-opercular networks predicts executive function performance in older adults. Neuropsychology, 30(3), 322-331. doi:10.1037/neu0000242 Seliger, S. L., Longstreth, W. T., Jr. (2008). Lessons about brain vascular disease from another pulsating organ, the kidney. Stroke, 39(1), 5-6. doi:10.1161/STROKEAHA.107.496000 Seo, S. W., Im, K., Lee, J. M., Kim, S. T., Ahn, H. J., Go, S. M., . . . Na, D. L. (2011). Effects of demographic factors on cortical thickness in Alzheimer's disease. Neurobiol Aging, 32(2), 200-209. doi:10.1016/j.neurobiolaging.2009.02.004 Shao, Z., Janse, E., Visser, K., Meyer, A. S. (2014). What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Frontiers in psychology, 5, 772. doi:10.3389/fpsyg.2014.00772 Shima, H., Ishimura, E., Naganuma, T., Ichii, M., Yamasaki, T., Mori, K., . . . Inaba, M. (2011). Decreased kidney function is a significant factor associated with silent cerebral infarction and periventricular hyperintensities. Kidney Blood Press Res, 34(6), 430-438. doi:10.1159/000328722 Sink, K. M., Divers, J., Whitlow, C. T., Palmer, N. D., Smith, S. C., Xu, J., . . . Freedman, B. I. (2015). Cerebral structural changes in diabetic kidney disease: African American-Diabetes Heart Study MIND. Diabetes Care, 38(2), 206-212. doi:10.2337/dc14-1231 Sink, K. M., Espeland, M. A., Castro, C. M., Church, T., Cohen, R., Dodson, J. A., . . . Investigators, L. S. (2015). Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial. Jama, 314(8), 781-790. doi:10.1001/jama.2015.9617 Slinin, Y., Paudel, M. L., Ishani, A., Taylor, B. C., Yaffe, K., Murray, A. M., . . . Osteoporotic Fractures in Men Study, G. (2008). Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc, 56(11), 2082-2088. doi:10.1111/j.1532-5415.2008.01936.x Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., . . . Phelps, C. H. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 7(3), 280-292. doi:10.1016/j.jalz.2011.03.003 Sun, Y., Lee, H. J., Yang, S. C., Chen, T. F., Lin, K. N., Lin, C. C., . . . Chiu, M. J. (2014). A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan. PLoS One, 9(6), e100303. doi:10.1371/journal.pone.0100303 Thomas, J. L., Jones, G. N., Scarinci, I. C., Mehan, D. J., Brantley, P. J. (2001). The utility of the CES-D as a depression screening measure among low-income women attending primary care clinics. The Center for Epidemiologic Studies-Depression. Int J Psychiatry Med, 31(1), 25-40. Tsai, C. F., Lee, W. J., Wang, S. J., Shia, B. C., Nasreddine, Z., Fuh, J. L. (2012). Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis. Int Psychogeriatr, 24(4), 651-658. doi:10.1017/s1041610211002298 van Guldener, C. (2006). Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant, 21(5), 1161-1166. doi:10.1093/ndt/gfl044 van Velsen, E. F., Vernooij, M. W., Vrooman, H. A., van der Lugt, A., Breteler, M. M., Hofman, A., . . . Ikram, M. A. (2013). Brain cortical thickness in the general elderly population: the Rotterdam Scan Study. Neurosci Lett, 550, 189-194. doi:10.1016/j.neulet.2013.06.063 Verfaillie, S. C., Tijms, B., Versteeg, A., Benedictus, M. R., Bouwman, F. H., Scheltens, P., . . . van der Flier, W. M. (2016). Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline. Alzheimers Dement (Amst), 5, 43-52. doi:10.1016/j.dadm.2016.10.007 Verfaillie, S. C. J., Slot, R. E., Tijms, B. M., Bouwman, F., Benedictus, M. R., Overbeek, J. M., . . . van der Flier, W. M. (2018). Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory. Neurobiol Aging, 61, 238-244. doi:10.1016/j.neurobiolaging.2017.09.009 Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., Breteler, M. M. (2003). Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med, 348(13), 1215-1222. doi:10.1056/NEJMoa022066 Vernooij, M. W., van der Lugt, A., Ikram, M. A., Wielopolski, P. A., Niessen, W. J., Hofman, A., . . . Breteler, M. M. (2008). Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology, 70(14), 1208-1214. doi:10.1212/01.wnl.0000307750.41970.d9 Vilagut, G., Forero, C. G., Barbaglia, G., Alonso, J. (2016). Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis. PLoS One, 11(5), e0155431. doi:10.1371/journal.pone.0155431 Vogels, S. C., Emmelot-Vonk, M. H., Verhaar, H. J., Koek, H. L. (2012). The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review. Maturitas, 71(4), 331-336. doi:10.1016/j.maturitas.2012.01.008 Wada, M., Nagasawa, H., Iseki, C., Takahashi, Y., Sato, H., Arawaka, S., . . . Kato, T. (2008). Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci, 272(1-2), 36-42. doi:10.1016/j.jns.2008.04.029 Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjogren, M., . . . Scheltens, P. (2001). A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke, 32(6), 1318-1322. Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., . . . Murray, C. J. L. (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1459-1544. doi:10.1016/s0140-6736(16)31012-1 Wechsler. (1997). In Wechsler Memory Scale for Adults, 3rd Ed. San Antonio, TX: The Psychological Corporation. White, S. L., Yu, R., Craig, J. C., Polkinghorne, K. R., Atkins, R. C., Chadban, S. J. (2011). Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis, 58(1), 19-28. doi:10.1053/j.ajkd.2010.12.026 Yakushiji, Y., Nanri, Y., Hirotsu, T., Nishihara, M., Hara, M., Nakajima, J., . . . Node, K. (2010). Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults. Hypertens Res, 33(12), 1232-1 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/57261 | - |
dc.description.abstract | 前言: 在老化社會中,失智症已造成嚴重的全球疾病負擔。使用腦部影像去分析大腦結構、例如計算腦部皮質厚度是否變薄,可作為認知功能退化前早期偵測的指標。另一方面,慢性腎臟病逐漸被認為也是造成失智症的危險因子之一,且同時也會造成腦部結構的變化,例如白質病變或者整體大腦萎縮。但過去較少研究討論到慢性腎臟病是否會造成腦部皮質厚度的變化,以及它們對尚未失智的老年人認知功能的長期影響。本論文涵蓋兩部分,首先是橫斷面地探討腎功能與腦部皮質厚度的關係,接著會研究腎功能失調與大腦皮質變薄兩者對於認知功能長期的影響。 第一部分: 腎功能失調與大腦皮質厚度的關聯 背景: 慢性腎病變者容易看到一些腦部結構性變化,例如腦部小血管疾病的表現或腦部整體萎縮。然而,過往較少文獻探討腎功能與大腦皮質厚度此一重要失智症影像指標的關聯性。本研究旨在研究正常認知功能老年人中、腎功能不良對於大腦皮質厚度的影響。 方法: 此一橫斷性研究納入了259位社區居住、認知功能無明顯失常之≥65歲之老年人,他們都接受了腦部核磁共振影像,並且經由FreeSurfer軟體來計算大腦整體以及不同皮質分區的皮質厚度,若某受試者該區塊皮質厚度介於整個族群的最低三分之一的話,則被定義為有皮質變薄。若經抽血計算出的腎絲球過濾率<60毫升/分鐘/1.73平方公尺、或尿液試紙顯示有1+以上的蛋白尿的話,則定義為有腎功能失調。 結果: 有腎功能失調的受試者(43位, 16.7%)其大腦整體皮質厚度明顯較無腎功能失調者較為薄(2.17±0.11 mm vs. 2.26±0.11 mm, P< 0.001)。在校正了年紀、性別、血管危險因子、APOE ε4帶因狀況、以及腦部白質病變和小洞性梗塞之後的多變項線性回歸模型中,腎功能失調與整體皮質厚度呈現負相關( = −0.04, 95%信賴區間 −0.08至 −0.01),也與其他額葉、頂葉、顳葉、枕葉及島葉呈負相關。在分層分析中,此現象在女性、APOE ε4非帶因者、以及認知功能分數較低者更為明顯。若將皮質變薄作為依變項的話,則腎功能失調會顯著增加島葉皮質變薄的危險(勝算比2.74, 95% 信賴區間1.31至5.74)。 結論: 由低腎絲球過濾率及蛋白尿所代表之腎功能失調,可能是大腦皮質變薄的獨立危險因子。在老年族群應嚴格監控腎功能以防止神經退化。 第二部分: 腎功能失調及大腦皮質變薄對認知功能變化的影響 背景: 大腦皮質變薄可作為預測老年族群認知功能衰退的影像指標,然而,慢性腎病變對於此相關性之間是否扮演有重要的角色、且對不同領域的認知面向是否有不同的影響尚不得而知。此外,腎功能失調與血管病變比較有關,而皮質變薄則可能與阿茲海默症的神經退化有關,兩者是否對於認知功能退化有加乘效應也尚未有研究。本研究旨在探討腎功能失調及大腦皮質變薄,對尚未失智的老人長期認知功能變化的影響。 方法: 此一長期追蹤研究納入了397位社區居住之≥65歲且有接受腦部核磁共振影像之老年人,在基線收案及之後每兩年都會接受一次完整認知功能檢驗,本研究納入了四年內的三次認知測驗,包括整體認知功能、專注力、執行功能、邏輯記憶、以及語言流暢度。在基線時的實驗室檢查數據中,若腎絲球過濾率<60毫升/分鐘/1.73平方公尺、或尿液試紙顯示有1+以上的蛋白尿的話,則定義為有腎功能失調。若任一次認知功能檢驗或實驗室檢查數據有遺失者,則會將其排除。受試者在基線也接受了腦部核磁共振影像,經FreeSurfer軟體計算出皮質厚度後,將整個族群的最低三分之一定義為皮質變薄,計算的皮質區塊包括整體、各皮質分葉,以及阿茲海默症區塊。為了處理重複測量之認知分數,統計使用廣義線性混合模型。 結果: 此研究最終納入244位受試者,並發現受試者基線的腎功能失調本身明顯與專注力退步有關(β=−0.29),與邏輯記憶減退有關的皮質變薄區塊包括整體皮質(β= −0.30)、阿茲海默症區塊(β= −0.36)、顳葉 (β= −0.31)、枕葉(β= −0.27)以及島葉(β= −0.28),而額葉變薄則與專注力(β= −0.26)以及執行功能(β =−0.26)的退步有關。腎功能失調會改變記憶功與整體皮質、額葉、邊緣系統變薄與記憶功能變化之間的關係(Pinteraction< 0.05),也就是腎功能失調者其皮質越薄反而記憶功能越好。若將腎功能失調與皮質變薄加乘考慮的話,則同時有腎功能失調且皮質變薄者,比上腎功能正常且皮質沒有變薄者,其專注力退步有明顯的趨勢效應(β= −0.51, Ptrend= 0.008)。 結論: 腎功能失調與皮質變薄對於認知功能退化有加乘效應,表示可能血管病變及阿茲海默相關的神經退化在老化過程的認知衰退中都扮演了重要角色。在腎功能不良者,皮質厚度與記憶功能可能存在反向關係。在老年族群中,有效監控甚至遏止腎功能變差可能可防止神經退化。 | zh_TW |
dc.description.abstract | Introduction: Dementia increase rapidly in the aging society and results in a huge global disease burden. Structural neuroimaging, such as cerebral cortical thickness (CTh), can serve as a biomarker to detect corresponding brain morphological change developed gradually before clinically detectable cognitive decline. Chronic kidney disease has been proposed as an independent risk factor for cognitive impairment and is also linked to brain structural abnormalities such as white matter lesion or generalized atrophy. However, only few studies explored the relationship between kidney function and CTh, as well as their effects on long-term cognitive change in non-demented elderly population. This dissertation consists of two parts: the first part focus on cross-sectional associations between kidney dysfunction and CTh, and the second part will investigate the impacts of kidney dysfunction and cortical thinning on cognitive change in a prospective cohort study. Part 1. Associations between kidney dysfunction and cortical thickness Background: Chronic kidney disease has been linked to morphological brain change, such as cerebral small vessel disease or brain atrophy. However, less is known about the relationship between kidney functions and cerebral cortical thickness. This study aimed to evaluate the potential impact of kidney dysfunction on cortical thickness in a group of independently living older persons. Methods: This cross-sectional study recruited 259 elderly participants from the annual elderly health checkup program. They received brain magnetic resonance image study, and the global and lobar cerebral cortical thickness (CTh) were calculated by FreeSurfer, a surface-based imaging analysis suite. Cortical thinning was defined as being lowest tertile of the global or lobar CTh. Glomerular filtration rate (GFR) and proteinuria were obtained from blood and urine sample, and kidney dysfunction was defined as either GFR <60 ml/min/1.73m2 or presence (≥ 1+) of proteinuria. Results: Participants with kidney dysfunction (n=43, 16.7%) had significantly thinner global CTh than those without kidney dysfunction (2.17±0.11 mm vs 2.26±0.11 mm, P<0.001). Kidney dysfunction was associated with thinner global ( = −0.04, 95% CI= −0.08 to −0.01) as well as frontal, parietal, temporal, occipital, and insular lobar CTh after adjustment of age, sex, vascular risk factors, APOE ε4 status, and MRI markers of small vessel disease. In the stratified analysis, the associations were more pronounced in women, APOE ε4 non-carriers, and participants with a lower cognitive score. Besides, kidney dysfunction significantly increased the risk of cortical thinning in the insular lobe (adjusted OR= 2.74, 95% CI= 1.31−5.74). Conclusion: Kidney dysfunction, represented by lower GFR or proteinuria, was independently related to cortical thinning. Kidney dysfunction should be closely monitored and managed in elderly population to prevent neurodegeneration. Part 2. Impacts of kidney dysfunction and cortical thinning on cognitive change Background: Cerebral cortical thinning is one important neuroimaging marker to predict cognitive decline in the elderly population. However, whether kidney dysfunction plays a crucial role or modifies the relationship between cortical thickness (CTh) and cognitive decline is unknown. This study aimed to investigate the associations of kidney dysfunction and cortical thinning on cognitive change in a prospective cohort design. Methods: This study recruited 397 elderly participants from elderly health checkup program in a tertiary medical center in Taiwan and all of them received with baseline brain MRI. They also received comprehensive exam at baseline and biannually afterwards (total 3 times). The neurocognitive tests administered at baseline and follow-up included global cognition, attention, executive function, logical memory, and verbal fluency. Laboratory study was collected at baseline, and kidney dysfunction was defined as having either glomerular filtration rate <60 ml/min/1.73m2 or proteinuria (≥ 1+). Those who had any missing cognitive exam or laboratory data were excluded. CTh of global, lobar, and Alzheimer’s disease (AD) signature area were derived from brain MRI at baseline, and cortical thinning was defined as the lowest tertile of cortical thickness. Generalized linear mixed models were applied to evaluate the effects of KD and cortical thinning on cognitive changes. Results: In total, 244 participants were included in the study. KD was associated with the decline in attention function (β= −0.29). Thinning of global (β= −0.30), AD signature area (β= −0.36), temporal (β= −0.31), occipital (β= −0.27) and insular lobes (β= −0.28) predicted poor logical memory over time, while frontal thinning predicted poor attention (β= −0.26) and executive function (β= −0.26). KD modified the relationship between thinning of global, frontal, and limbic, and change of logical memory function (Pinteraction< 0.05). When considering jointly, participants with both KD and cortical thinning had greatest decline in attention function compared with those without KD or cortical thinning (β= −0.51, Ptrend= 0.008). Conclusion: Kidney dysfunction and cortical thinning have joint effect on cognitive decline, especially the attention function. Reverse associations may exist between cortical thinning and memory function in participants with kidney dysfunction. The role of kidney dysfunction in the process of neurodegeneration should be emphasized. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T06:39:35Z (GMT). No. of bitstreams: 1 U0001-2207202010443600.pdf: 11173726 bytes, checksum: 6ebab92d5e03ba493e18ff2a9ebe0bfe (MD5) Previous issue date: 2020 | en |
dc.description.tableofcontents | 口試委員審定書 ii 致謝 iii 中文摘要 iv Abstract vii List of Figures xi List of Tables xii Chapter 1. Introduction 1 1.1 Chronic kidney disease 1 1.2 Dementia and mild cognitive impairment 4 1.3 Neurocognitive assessment 8 1.4 Neuroimaging biomarker for dementia 11 1.5 Brain-kidney interaction 15 1.6 Aims of the study 18 Chapter 2. Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population 23 2.1 Introduction 23 2.2 Research gap and aim of the study 25 2.3 Materials and methods 26 2.4 Results 31 2.5 Discussion 33 Chapter 3. Impacts of Kidney Dysfunction and Cerebral Cortical Thinning on Cognitive Change in Elderly Population 48 3.1 Introduction 48 3.2 Research gap and aim of the study 50 3.3 Materials and methods 51 3.4 Results 56 3.5 Discussion 61 Chapter 4. Conclusions 85 4.1. Clinical and policy implications and future perspectives 86 References 88 Appendix 1. MoCA-T questionnaire 100 Appendix 2. Published paper, first part 101 Appendix 3. Published paper, second part 109 | |
dc.language.iso | en | |
dc.title | 腎功能障礙對老年人之腦部皮質厚度與 認知功能變化之研究 | zh_TW |
dc.title | Effects of Kidney Dysfunction on Cerebral Cortical Thickness and Cognitive Change in the Elderly | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-2 | |
dc.description.degree | 博士 | |
dc.contributor.author-orcid | 0000-0002-1258-8775 | |
dc.contributor.oralexamcommittee | 丘政民(Jeng-min Chiou),李文宗(Wen-Chung Lee),陳達夫(Ta-Fu Chen),嚴崇仁(Chung-Jen Yen),陳人豪(Jen-Hau Chen) | |
dc.subject.keyword | 認知功能,核磁共振,皮質厚度,腎功能,腎絲球過濾率,蛋白尿, | zh_TW |
dc.subject.keyword | cognitive,magnetic resonance imaging,cortical thickness,kidney function,glomerular filtration rate,proteinuria, | en |
dc.relation.page | 120 | |
dc.identifier.doi | 10.6342/NTU202001721 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2020-07-23 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-2207202010443600.pdf 目前未授權公開取用 | 10.91 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。